Two Doses of GHB04L1 for Pandemic Influenza Prophylaxis in Healthy Adults

NCT03745274 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AVIR Green Hills Biotechnology AG